Table 4

Relationship between ACF and hyperplastic polyps

EndpointPatients with hyperplastic polyps, n = 18Patients without hyperplastic polyps, n = 27
Placebo twice daily (n = 6)Celecoxib twice daily (n = 12)Placebo twice daily (n = 11)Celecoxib twice daily (n = 16)
Cases with no ACF identified, n (%)1 (17)2 (17)2 (18)2 (13)
Average ACF count per patient ± SE11.0 ± 4.512.7 ± 4.314.7 ± 5.516.4 ± 4.5

NOTE: Neither the presence of ACF in a given patient or the average number of ACF per patient predicted the presence of hyperplastic polyps in the entire colorectum.